{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:06:45Z","timestamp":1790140005650,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020830","name":"Ayumi Pharmaceutical Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020830","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal Plus: Cardiology Research and Practice"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ahjo.2026.100743","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T17:30:38Z","timestamp":1772559038000},"page":"100743","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Analgesic use and changes in renal function in patients with heart failure in a real-world setting: a descriptive study using an electronic medical record database"],"prefix":"10.1016","volume":"64","author":[{"given":"Ryo","family":"Ishida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Takano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironobu","family":"Tokumasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ahjo.2026.100743_bb0005","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and stroke statistics-2021 update: a report from the American Heart Association","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ahjo.2026.100743_bb0010","series-title":"Vital Statistics of Japan","first-page":"28","article-title":"Director-General for statistics, information policy and industrial relations, Ministry of Health, Labour, and Welfare, Japan","year":"2019"},{"issue":"12","key":"10.1016\/j.ahjo.2026.100743_bb0015","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1253\/circj.CJ-21-0431","article-title":"JCS\/JHFS 2021 guideline focused update on diagnosis and treatment of acute and chronic heart failure","volume":"85","author":"Tsutsui","year":"2021","journal-title":"Circ. J."},{"issue":"36","key":"10.1016\/j.ahjo.2026.100743_bb0020","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"issue":"18","key":"10.1016\/j.ahjo.2026.100743_bb0025","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the Management of Heart Failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ahjo.2026.100743_bb0030","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.hrtlng.2021.04.016","article-title":"Pain intensity and pain medication prescription patterns in veterans with heart failure and back pain","volume":"50","author":"Cavanagh","year":"2021","journal-title":"Heart Lung"},{"issue":"10","key":"10.1016\/j.ahjo.2026.100743_bb0035","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.cardfail.2012.07.007","article-title":"Investigating pain in heart failure patients: the pain assessment, incidence, and nature in heart failure (PAIN-HF) study","volume":"18","author":"Goodlin","year":"2012","journal-title":"J. Card. Fail."},{"issue":"5","key":"10.1016\/j.ahjo.2026.100743_bb0040","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1253\/circj.CJ-20-1127","article-title":"JCS\/JHFS 2021 statement on palliative care in cardiovascular diseases","volume":"85","author":"Anzai","year":"2021","journal-title":"Circ. J."},{"issue":"1","key":"10.1016\/j.ahjo.2026.100743_bb0045","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10741-016-9581-4","article-title":"Symptom burden in heart failure: assessment, impact on outcomes, and management","volume":"22","author":"Alpert","year":"2017","journal-title":"Heart Fail. Rev."},{"issue":"23","key":"10.1016\/j.ahjo.2026.100743_bb0050","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/eurheartj\/ehv010","article-title":"The kidney in heart failure: an update","volume":"36","author":"Damman","year":"2015","journal-title":"Eur. Heart J."},{"issue":"7","key":"10.1016\/j.ahjo.2026.100743_bb0055","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/eurheartj\/eht386","article-title":"Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis","volume":"35","author":"Damman","year":"2014","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.ahjo.2026.100743_bb0060","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003588","article-title":"Renin-angiotensin system inhibition, worsening renal function, and outcome in heart failure patients with reduced and preserved ejection fraction: a meta-analysis of published study data","volume":"10","author":"Beldhuis","year":"2017","journal-title":"Circ. Heart Fail."},{"issue":"6","key":"10.1016\/j.ahjo.2026.100743_bb0065","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/jch.12821","article-title":"Blockade of the renin-angiotensin system and the risk of acute kidney injury","volume":"18","author":"Burnier","year":"2016","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"key":"10.1016\/j.ahjo.2026.100743_bb0070","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e8525","article-title":"Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study","volume":"346","author":"Lapi","year":"2013","journal-title":"Bmj"},{"issue":"1","key":"10.1016\/j.ahjo.2026.100743_bb0075","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11255-020-02596-7","article-title":"Influence of acetaminophen on renal function: a longitudinal descriptive study using a real-world database","volume":"53","author":"Ide","year":"2021","journal-title":"Int. Urol. Nephrol."},{"issue":"2","key":"10.1016\/j.ahjo.2026.100743_bb0080","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.mayocp.2019.12.004","article-title":"Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors versus other classes of glucose-lowering medications on renal outcome in type 2 diabetes","volume":"95","author":"Takeuchi","year":"2020","journal-title":"Mayo Clin. Proc."},{"issue":"1","key":"10.1016\/j.ahjo.2026.100743_bb0085","doi-asserted-by":"crossref","first-page":"9095","DOI":"10.1038\/s41598-024-60011-y","article-title":"Initiation and continuation of pharmacological therapies in patients hospitalized for heart failure in Japan","volume":"14","author":"Okami","year":"2024","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.ahjo.2026.100743_bb0090","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1053\/j.ajkd.2014.08.018","article-title":"GFR decline and subsequent risk of established kidney outcomes: a meta-analysis of 37 randomized controlled trials","volume":"64","author":"Lambers Heerspink","year":"2014","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ahjo.2026.100743_bb0095","series-title":"Generalized Additive Models: An Introduction with R","first-page":"172","volume":"83","author":"Wood","year":"2017"},{"issue":"6","key":"10.1016\/j.ahjo.2026.100743_bb0100","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am. J. Kidney Dis."},{"issue":"4","key":"10.1016\/j.ahjo.2026.100743_bb0105","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","article-title":"Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate","volume":"145","author":"Levey","year":"2006","journal-title":"Ann. Intern. Med."},{"issue":"2","key":"10.1016\/j.ahjo.2026.100743_bb0110","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/ageing\/afx180","article-title":"Association of estimated glomerular filtration rate with muscle function in older persons who have fallen","volume":"47","author":"Tap","year":"2018","journal-title":"Age Ageing"},{"issue":"4","key":"10.1016\/j.ahjo.2026.100743_bb0115","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/gutjnl-2019-319300","article-title":"Non-steroidal anti-inflammatory drug (NSAID) therapy in patients with hypertension, cardiovascular, renal or gastrointestinal comorbidities: joint APAGE\/APLAR\/APSDE\/APSH\/APSN\/PoA recommendations","volume":"69","author":"Szeto","year":"2020","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.ahjo.2026.100743_bb0120","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1053\/j.ajkd.2020.03.023","article-title":"NSAIDs in CKD: are they safe?","volume":"76","author":"Baker","year":"2020","journal-title":"Am. J. Kidney Dis."},{"issue":"2","key":"10.1016\/j.ahjo.2026.100743_bb0125","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/ejp.2176","article-title":"Prevalence of chronic pain and chronic widespread pain among subjects with heart failure in the general population: the HUNT study","volume":"28","author":"Vikan","year":"2024","journal-title":"Eur. J. Pain"},{"issue":"1","key":"10.1016\/j.ahjo.2026.100743_bb0130","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s12882-017-0673-8","article-title":"Non-steroidal anti-inflammatory drug induced acute kidney injury in the community dwelling general population and people with chronic kidney disease: systematic review and meta-analysis","volume":"18","author":"Zhang","year":"2017","journal-title":"BMC Nephrol."},{"issue":"8","key":"10.1016\/j.ahjo.2026.100743_bb0135","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-005581","article-title":"Analgesia dose prescribing and estimated glomerular filtration rate decline: a general practice database linkage cohort study","volume":"4","author":"Nderitu","year":"2014","journal-title":"BMJ Open"},{"issue":"Supplement_1","key":"10.1016\/j.ahjo.2026.100743_bb0140","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehae666.1226","article-title":"Paracetamol and adverse cardiovascular outcomes in patients with heart failure","volume":"45","author":"Ren","year":"2024","journal-title":"Eur. Heart J."},{"issue":"21","key":"10.1016\/j.ahjo.2026.100743_bb0145","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1002\/sim.9505","article-title":"Generalized additive models to analyze nonlinear trends in biomedical longitudinal data using R: beyond repeated measures ANOVA and linear mixed models","volume":"41","author":"Mundo","year":"2022","journal-title":"Stat. Med."},{"issue":"12","key":"10.1016\/j.ahjo.2026.100743_bb0150","first-page":"193","article-title":"Cardiogenic causes of fever","volume":"115","author":"Smid","year":"2018","journal-title":"Dtsch. Arztebl. Int."},{"issue":"3","key":"10.1016\/j.ahjo.2026.100743_bb0155","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/phar.2231","article-title":"Augmented renal clearance","volume":"39","author":"Cook","year":"2019","journal-title":"Pharmacotherapy"},{"issue":"11","key":"10.1016\/j.ahjo.2026.100743_bb0160","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"10254","key":"10.1016\/j.ahjo.2026.100743_bb0165","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(20)31824-9","article-title":"SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-reduced and DAPA-HF trials","volume":"396","author":"Zannad","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ahjo.2026.100743_bb0170","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/eurheartj\/ehaa736","article-title":"Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine","volume":"42","author":"Agarwal","year":"2021","journal-title":"Eur. Heart J."},{"issue":"10367","key":"10.1016\/j.ahjo.2026.100743_bb0175","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/S0140-6736(22)02076-1","article-title":"Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial","volume":"400","author":"Mebazaa","year":"2022","journal-title":"Lancet"}],"container-title":["American Heart Journal Plus: Cardiology Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666602226000315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666602226000315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:31:43Z","timestamp":1790137903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666602226000315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":35,"alternative-id":["S2666602226000315"],"URL":"https:\/\/doi.org\/10.1016\/j.ahjo.2026.100743","relation":{},"ISSN":["2666-6022"],"issn-type":[{"value":"2666-6022","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analgesic use and changes in renal function in patients with heart failure in a real-world setting: a descriptive study using an electronic medical record database","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal Plus: Cardiology Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahjo.2026.100743","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100743"}}